JAZZ
Jazz Pharmaceuticals PLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$14.48B
P/E Ratio
1921.33
EPS
$0.12
Beta
0.33
52W High
$243.32
52W Low
$105.00
50-Day MA
$217.29
200-Day MA
$173.04
Dividend Yield
—
Profit Margin
0.66%
Forward P/E
12.58
PEG Ratio
0.96
About Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland.
Fundamentals
| Revenue (TTM) | $4.44B |
| Gross Profit (TTM) | $4.06B |
| EBITDA | $2.01B |
| Operating Margin | 23.50% |
| Return on Equity | 0.68% |
| Return on Assets | 6.92% |
| Revenue/Share (TTM) | $72.52 |
| Book Value | $72.28 |
| Price-to-Book | 3.20 |
| Price-to-Sales (TTM) | 3.26 |
| EV/Revenue | 3.836 |
| EV/EBITDA | 25.21 |
| Quarterly Earnings Growth (YoY) | 3.20% |
| Quarterly Revenue Growth (YoY) | 19.10% |
| Shares Outstanding | $62.82M |
| Float | $60.81M |
| % Insiders | 3.12% |
| % Institutions | 108.36% |
Historical Volatility
HV 10-Day
38.49%
HV 20-Day
30.19%
HV 30-Day
34.66%
HV 60-Day
30.94%
HV Rank
70.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($255.95 target)
7
Strong Buy10
Buy1
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026